NSCLC molecular biomarkers
Nov 29, 2024
The Next Chapter in NSCLC Treatment Space: Recent Discoveries and Innovations
Lung cancer was the most prevalent cancer globally, with 2.5 million new cases, representing 12.4% of all new cancer diagnoses. NSCLC is the most common type of lung cancer, accounting for over 85% of all cases. As per the latest estimates, the total incident cases of NSCLC in the 7MM were approximately 500K cases ...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
